| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/20/2003 | WO2002061057A3 Regulation of human wee1-like serine/threonine protein kinase |
| 02/20/2003 | WO2002057307A3 Genes |
| 02/20/2003 | WO2002055651A3 Processes and vectors for plastid transformation |
| 02/20/2003 | WO2002052012A8 Sugar beet genes involved in stress tolerance |
| 02/20/2003 | WO2002044344A3 Basal cell carcinoma cultures, methods related thereto and their use |
| 02/20/2003 | WO2002029075A9 Multiple inducible gene regulation system |
| 02/20/2003 | WO2002028420A9 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 02/20/2003 | WO2002026950A3 Transferases |
| 02/20/2003 | WO2002012452A3 Pancreatic progenitor cells |
| 02/20/2003 | WO2001072325A9 Methods of blocking tissue destruction by autoreactive t cells |
| 02/20/2003 | US20030037354 Animal model for use in the diagnosis and treatment of nervous system disorders |
| 02/20/2003 | US20030037352 Generation of genetically engineered animal embryos; obtain oocyte, insert into diploid nucleus, activate oocyte, propagate and recover viable offspring |
| 02/20/2003 | US20030037351 Nucleic acid regulatory sequences and uses therefor |
| 02/20/2003 | US20030037345 Compositions and methods for wound healing |
| 02/20/2003 | US20030036801 Cartilage repair apparatus and method |
| 02/20/2003 | US20030036646 Uncoupling protein polynucleotides, polypeptides, and antibodies |
| 02/20/2003 | US20030036635 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036634 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036633 DNA encoding bradykinin B1 receptor |
| 02/20/2003 | US20030036631 Protein for use in the treatment of asthma, leukemia, or other allergic or inflammatory defects |
| 02/20/2003 | US20030036630 Nucleotide sequences for use in human therapeutics and diagnostics |
| 02/20/2003 | US20030036523 Of undifferentiated mesenchyma; having the ability to express Tbr-1, Brachyury or another member of the T-box family. |
| 02/20/2003 | US20030036522 Pluripotent cells suitable for transplantation therapy, to repair neural damage, are identified, e.g. by differential display, from a gene expression profile for a selected cell, which can be compared with that obtained from a control cell |
| 02/20/2003 | US20030036505 Signal transduction pathway component polynucleotides, polypeptides, antibodies and methods based thereon |
| 02/20/2003 | US20030036197 Recombinant constructs and their use in reducing gene expression |
| 02/20/2003 | US20030036196 Solid support for use in the propagation of preferential cells |
| 02/20/2003 | US20030036195 Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use |
| 02/20/2003 | US20030036194 Genetically engineered cell for use in regenerative medicine |
| 02/20/2003 | US20030036193 Inducing the migration of progenitor cells into regions of nervous tissue damage; identify region of nervous tissue damage, incubate with progenitor cells and transforming growth factor, monitor therapeutic response |
| 02/20/2003 | US20030036185 Novel amino acid sequences for human kidney cadherin-like polypeptides |
| 02/20/2003 | US20030036184 Polypeptides exhibiting PDE7 activity and their use for selecting compounds which inhibit PDE 7 enzyme activity |
| 02/20/2003 | US20030036180 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036178 Long wavelength engineered fluorescent proteins |
| 02/20/2003 | US20030036169 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's diseases |
| 02/20/2003 | US20030036168 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/20/2003 | US20030036167 Protease proteins that are related to the choriolytic hatching protease subfamily, recombinant DNA molecules, and protein production. |
| 02/20/2003 | US20030036166 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 02/20/2003 | US20030036165 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036162 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036161 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036146 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036140 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036137 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036121 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036119 Nucleotide sequences coding polypeptides for use in the treatment, diagnosis and prevention of cell proliferative disorders |
| 02/20/2003 | US20030036118 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036116 Can be used in combination with other mutagenesis methods |
| 02/20/2003 | US20030036112 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 02/20/2003 | US20030036110 Isolation of viral envelope proteins; obtain cells transform with vector containing viral protein, propagate cell, lyse cells, recover envelope proteins |
| 02/20/2003 | US20030036094 Nucleotide sequences coding polypeptide for use in the treatment of kidney, skin and cancer disorders |
| 02/20/2003 | US20030036088 Separation of viruses in sample; obtain sample containing viruses, incubate with filter, recover and analyze preferential virus from filter |
| 02/20/2003 | US20030036076 CADs as modifiers of the p53 pathway and methods of use |
| 02/20/2003 | US20030036075 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 02/20/2003 | US20030036061 Nucloetide sequences coding polypeptide for use in the treatment and diagnosis of infections,cancer, skin, cardiovascular and gastrointestinal disorders |
| 02/20/2003 | US20030036060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036055 Generation of vector containing preferential insert; obtain nucleotide sequences, incubate with primers, amplify, recover nucleotide sequences |
| 02/20/2003 | US20030036051 Methods of screening for antagonists and agonists of polypeptides having kinase functions |
| 02/20/2003 | US20030035843 Method for processing and preserving collagen-based tissues for transplantation |
| 02/20/2003 | US20030035829 Liposomal compositions for the delivery of nucleic acid catalysts |
| 02/20/2003 | US20030035820 Crosslinked keratin; thin film; wound healing agents, tissues, diffusion membranes |
| 02/20/2003 | US20030035816 Soluble ctla4 mutant molecules and uses thereof |
| 02/20/2003 | US20030035799 Glycosylated antibody |
| 02/20/2003 | US20030035798 Prevention infections; such as colds, influenza |
| 02/20/2003 | US20030035792 Recombinant MVA virus, and the use thereof |
| 02/20/2003 | US20030035789 Purging lymphocytes |
| 02/20/2003 | US20030034993 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | CA2808328A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | CA2790951A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | CA2467919A1 Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease |
| 02/20/2003 | CA2463930A1 Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof |
| 02/20/2003 | CA2457694A1 Platelet-derived growth factor protection of cardiac myocardium |
| 02/20/2003 | CA2457448A1 Human smooth muscle myosin heavy chain |
| 02/20/2003 | CA2457322A1 Process for the maturation of dentritic cells and a vaccine |
| 02/20/2003 | CA2457059A1 System for detecting protease |
| 02/20/2003 | CA2456909A1 Methods for the treatment and prognosis of leukemia and other cancer types |
| 02/20/2003 | CA2456882A1 Modified cyclic nucleotide gated ion channel (cng) comprising methionine or valine substitutions at t537 and uses thereof |
| 02/20/2003 | CA2456857A1 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof |
| 02/20/2003 | CA2456723A1 Inhibitors of her3 activity |
| 02/20/2003 | CA2456565A1 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/20/2003 | CA2456552A1 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 02/20/2003 | CA2456369A1 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | CA2456311A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | CA2456271A1 Use of lysyl oxidase inhibitors for cell culture and tissue engineering |
| 02/20/2003 | CA2454910A1 Erythrocytic cells and method for preserving cells |
| 02/20/2003 | CA2454684A1 Eukaryotic cells and method for preserving cells |
| 02/20/2003 | CA2454251A1 Isolation and mobilization of stem cells expressing vegfr-1 |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | CA2453248A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | CA2452842A1 13 human secreted proteins |
| 02/20/2003 | CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | CA2450780A1 Novel recombinant gene expression method by stop codon suppression |
| 02/19/2003 | EP1284290A1 Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA |
| 02/19/2003 | EP1284285A2 Method for collecting cells in M phase or G1 phase and method for nuclear transplantation using the cells |
| 02/19/2003 | EP1284284A2 Cell culture model for arteriosclerosis |
| 02/19/2003 | EP1284144A1 Anti-tumor vaccines |
| 02/19/2003 | EP1283895A2 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 02/19/2003 | EP1283889A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome) |
| 02/19/2003 | EP1283887A1 Chimeric arterivirus-like particles |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |